Moulari B[au] - Search Results

Year	Number of Results
2006	2
2007	3
2008	1
2010	1
2011	2
2012	2
2013	2
2014	2
2016	2
2017	1
2020	1
2021	3
2022	1
2023	0

1

Nanoparticle targeting to inflamed tissues of the gastrointestinal tract.

Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Moulari B, et al. Curr Drug Deliv. 2013 Feb;10(1):9-17. doi: 10.2174/1567201811310010004. Curr Drug Deliv. 2013. PMID: 22998041 Review.

2

Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting.

Ries M, Moulari B, Shetab Boushehri MA, Ali ME, Molnar D, Béduneau A, Pellequer Y, Lamprecht A. Ries M, et al. Among authors: moulari b. Pharmaceutics. 2022 Feb 2;14(2):352. doi: 10.3390/pharmaceutics14020352. Pharmaceutics. 2022. PMID: 35214083 Free PMC article.

3

Amelioration of murine experimental colitis using biocompatible cyclosporine A lipid carriers.

Scarcello E, Abdel-Mottaleb MMA, Beduneau A, Moulari B, Pellequer Y. Scarcello E, et al. Among authors: moulari b. Drug Deliv Transl Res. 2021 Jun;11(3):1301-1308. doi: 10.1007/s13346-020-00835-z. Drug Deliv Transl Res. 2021. PMID: 32794147

4

Surface-charge-dependent nanoparticles accumulation in inflamed skin.

Abdel-Mottaleb MM, Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Abdel-Mottaleb MM, et al. Among authors: moulari b. J Pharm Sci. 2012 Nov;101(11):4231-9. doi: 10.1002/jps.23282. Epub 2012 Aug 1. J Pharm Sci. 2012. PMID: 22855370

5

Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid formulations in experimental colitis.

Jhundoo HD, Siefen T, Liang A, Schmidt C, Lokhnauth J, Moulari B, Béduneau A, Pellequer Y, Larsen CC, Lamprecht A. Jhundoo HD, et al. Among authors: moulari b. Int J Pharm X. 2021 Apr 24;3:100080. doi: 10.1016/j.ijpx.2021.100080. eCollection 2021 Dec. Int J Pharm X. 2021. PMID: 33997765 Free PMC article.

6

Hyaluronic Acid Increases Anti-Inflammatory Efficacy of Rectal 5-Amino Salicylic Acid Administration in a Murine Colitis Model.

Jhundoo HD, Siefen T, Liang A, Schmidt C, Lokhnauth J, Moulari B, Béduneau A, Pellequer Y, Larsen CC, Lamprecht A. Jhundoo HD, et al. Among authors: moulari b. Biomol Ther (Seoul). 2021 Sep 1;29(5):536-544. doi: 10.4062/biomolther.2020.227. Biomol Ther (Seoul). 2021. PMID: 34059563 Free PMC article.

7

Surfactant-dependence of nanoparticle treatment in murine experimental colitis.

Wachsmann P, Moulari B, Béduneau A, Pellequer Y, Lamprecht A. Wachsmann P, et al. Among authors: moulari b. J Control Release. 2013 Nov 28;172(1):62-68. doi: 10.1016/j.jconrel.2013.07.031. Epub 2013 Aug 9. J Control Release. 2013. PMID: 23933520

8

Nanoparticles enhance therapeutic outcome in inflamed skin therapy.

Abdel-Mottaleb MM, Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Abdel-Mottaleb MM, et al. Among authors: moulari b. Eur J Pharm Biopharm. 2012 Sep;82(1):151-7. doi: 10.1016/j.ejpb.2012.06.006. Epub 2012 Jun 19. Eur J Pharm Biopharm. 2012. PMID: 22728016

9

Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution.

Montesinos RN, Moulari B, Gromand J, Beduneau A, Lamprecht A, Pellequer Y. Montesinos RN, et al. Among authors: moulari b. Drug Metab Dispos. 2014 Apr;42(4):700-6. doi: 10.1124/dmd.113.055566. Epub 2014 Jan 7. Drug Metab Dispos. 2014. PMID: 24398461

10

Nanosphere-shaped ammonio methacrylate copolymers: converting a pharmaceutical inactive ingredient to efficient therapeutics for experimental colitis.

Moulari B , Shetab Boushehri MA , Pais de Barros JP , Faber T , Béduneau A , Lagrost L , Pellequer Y , Lamprecht A . Moulari B , et al. Nanoscale. 2020 May 7;12(17):9590-9602. doi: 10.1039/d0nr00465k. Epub 2020 Apr 21. Nanoscale. 2020. PMID: 32314992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results